Open study of AL-721 treatment of HIV-infected subjects with generalized lymphadenopathy syndrome: An eight week open trial and follow-up
- 1 April 1988
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 9 (3), 177-190
- https://doi.org/10.1016/0166-3542(88)90002-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- HIV ANTIGENAEMIA AND VIRUS ISOLATION FROM PLASMA DURING PRIMARY HIV INFECTIONThe Lancet, 1987
- CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL EFFECTS OF AMPLIGEN, A MISMATCHED DOUBLE-STRANDED RNA, IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1987
- Antigenemia and Antibody Titers to Core and Envelope Antigens in AIDS, AIDS-Related Complex, and Subclinical Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1987
- Effects of a Novel Compound (AL 721) on HTLV-III Infectivity in VitroNew England Journal of Medicine, 1985
- HTLV-III Viremia in Homosexual Men with Generalized LymphadenopathyNew England Journal of Medicine, 1985
- A special lipid mixture for membrane fluidizationBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- Lymphadenopathy-Associated Viral Antibody in AIDSNew England Journal of Medicine, 1984
- Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDSScience, 1984